Internal Medicine, Nephrology · Coral Gables, FL
NPI
1003816463
Since 2005
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
747 Ponce de Leon Blvd, Suite 605
Coral Gables, FL, 33134
Phone (305) 445-4535
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
307 services
Medicare patients, 2024
61
Average age 77
Drug cost, 2024
$3.4M
5,995 prescriptions
Company payments, 2025
$20K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Luis R Garcia-Mayol was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 101 times for 44 patients. In total Luis R Garcia-Mayol billed 307 services in 10 codes, and Medicare paid $27K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-10-21.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 101 | 44 | $12.76 | $1,289 |
| 99214 Office E&M - Established | Office | 82 | 36 | $93.82 | $7,693 |
By year: 2022 $80K for 393 services; 2023 $62K for 352 services; 2024 $27K for 307 services.
Medicare prescription drug claims, 2024
In 2024, the drug Luis R Garcia-Mayol prescribed most often to Medicare patients was Farxiga (Dapagliflozin Propanediol), with 1,429 prescriptions and refills. In total Luis R Garcia-Mayol wrote 5,995 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Farxiga Dapagliflozin Propanediol | 1,429 | 2,097 | 303 | $1.2M |
| Kerendia Finerenone | 483 | 698 | 96 | $446K |
| Bumetanide Generic | 439 | 827 | 101 | $11K |
| Veltassa Patiromer Calcium Sorbitex | 404 | 455 | 126 | $449K |
| Irbesartan Generic | 328 | 904 | 112 | $4,536 |
| Jardiance Empagliflozin | 292 | 492 | 63 | $290K |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 214 | 353 | 54 | $950 |
| Clonidine Hcl Generic | 200 | 338 | 51 | $850 |
| Amlodipine Besylate Generic | 190 | 455 | 53 | $462 |
| Sevelamer Carbonate Generic | 151 | 215 | 40 | $21K |
| Losartan Potassium Generic | 135 | 349 | 44 | $796 |
| Allopurinol Generic | 133 | 314 | 37 | $523 |
| Lisinopril Generic | 109 | 281 | 33 | $554 |
| Calcitriol Generic | 96 | 234 | 30 | $2,209 |
| Nifedipine Er Nifedipine | 93 | 239 | 27 | $2,028 |
Brand drugs: 3,000 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Luis R Garcia-Mayol $20K ($20K in general payments such as food, travel and fees) from 17 companies. The largest payer was Vifor Pharma, Inc. with $18K.
| Company | Payments | Amount |
|---|---|---|
| Vifor Pharma, Inc. | 34 | $18K |
| Ardelyx, Inc. ARDX | 5 | $207 |
| Aurinia Pharma U.S., Inc. AUPH | 3 | $171 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 5 | $138 |
| Lilly USA, LLC LLY | 5 | $130 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $118 |
| Mallinckrodt Hospital Products Inc. | 4 | $116 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $100 |
| Amgen Inc. AMGN | 3 | $73.99 |
| Calliditas Therapeutics US Inc. | 3 | $73.08 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.